339 related articles for article (PubMed ID: 32302703)
1. Considerations for drug interactions on QTc interval in exploratory COVID-19 treatment.
Roden DM; Harrington RA; Poppas A; Russo AM
Heart Rhythm; 2020 Jul; 17(7):e231-e232. PubMed ID: 32302703
[No Abstract] [Full Text] [Related]
2. QT Interval Prolongation Under Hydroxychloroquine/Azithromycin Association for Inpatients With SARS-CoV-2 Lower Respiratory Tract Infection.
Bun SS; Taghji P; Courjon J; Squara F; Scarlatti D; Theodore G; Baudouy D; Sartre B; Labbaoui M; Dellamonica J; Doyen D; Marquette CH; Levraut J; Esnault V; Bun SS; Ferrari E
Clin Pharmacol Ther; 2020 Nov; 108(5):1090-1097. PubMed ID: 32588427
[TBL] [Abstract][Full Text] [Related]
3. The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin.
Chorin E; Dai M; Shulman E; Wadhwani L; Bar-Cohen R; Barbhaiya C; Aizer A; Holmes D; Bernstein S; Spinelli M; Park DS; Chinitz LA; Jankelson L
Nat Med; 2020 Jun; 26(6):808-809. PubMed ID: 32488217
[No Abstract] [Full Text] [Related]
4. Considerations for Drug Interactions on QTc Interval in Exploratory COVID-19 Treatment.
Roden DM; Harrington RA; Poppas A; Russo AM
J Am Coll Cardiol; 2020 May; 75(20):2623-2624. PubMed ID: 32283123
[No Abstract] [Full Text] [Related]
5. QT Interval Control to Prevent Torsades de Pointes during Use of Hydroxychloroquine and/or Azithromycin in Patients with COVID-19.
Wu TC; Sacilotto L; Darrieux FCDC; Pisani CF; Melo SL; Hachul DT; Scanavacca M
Arq Bras Cardiol; 2020 Jun; 114(6):1061-1066. PubMed ID: 32638906
[No Abstract] [Full Text] [Related]
6. Predictive factors for cardiac conduction abnormalities with hydroxychloroquine-containing combinations for COVID-19.
Padilla S; Telenti G; Guillén L; García JA; García-Abellán J; Ding C; Mora A; García-Pachón E; Gutiérrez F; Masiá M;
Int J Antimicrob Agents; 2020 Oct; 56(4):106142. PubMed ID: 32853675
[TBL] [Abstract][Full Text] [Related]
7. Considerations for Drug Interactions on QTc in Exploratory COVID-19 Treatment.
Roden DM; Harrington RA; Poppas A; Russo AM
Circulation; 2020 Jun; 141(24):e906-e907. PubMed ID: 32267732
[No Abstract] [Full Text] [Related]
8. Arrhythmic profile and 24-hour QT interval variability in COVID-19 patients treated with hydroxychloroquine and azithromycin.
Cipriani A; Zorzi A; Ceccato D; Capone F; Parolin M; Donato F; Fioretto P; Pesavento R; Previato L; Maffei P; Saller A; Avogaro A; Sarais C; Gregori D; Iliceto S; Vettor R
Int J Cardiol; 2020 Oct; 316():280-284. PubMed ID: 32439366
[TBL] [Abstract][Full Text] [Related]
9. Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19).
Giudicessi JR; Noseworthy PA; Friedman PA; Ackerman MJ
Mayo Clin Proc; 2020 Jun; 95(6):1213-1221. PubMed ID: 32359771
[TBL] [Abstract][Full Text] [Related]
10. Experience With Hydroxychloroquine and Azithromycin in the Coronavirus Disease 2019 Pandemic: Implications for QT Interval Monitoring.
Ramireddy A; Chugh H; Reinier K; Ebinger J; Park E; Thompson M; Cingolani E; Cheng S; Marban E; Albert CM; Chugh SS
J Am Heart Assoc; 2020 Jun; 9(12):e017144. PubMed ID: 32463348
[TBL] [Abstract][Full Text] [Related]
11. QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/azithromycin.
Chorin E; Wadhwani L; Magnani S; Dai M; Shulman E; Nadeau-Routhier C; Knotts R; Bar-Cohen R; Kogan E; Barbhaiya C; Aizer A; Holmes D; Bernstein S; Spinelli M; Park DS; Stefano C; Chinitz LA; Jankelson L
Heart Rhythm; 2020 Sep; 17(9):1425-1433. PubMed ID: 32407884
[TBL] [Abstract][Full Text] [Related]
12. Cardiac Corrected QT Interval Changes Among Patients Treated for COVID-19 Infection During the Early Phase of the Pandemic.
Rubin GA; Desai AD; Chai Z; Wang A; Chen Q; Wang AS; Kemal C; Baksh H; Biviano A; Dizon JM; Yarmohammadi H; Ehlert F; Saluja D; Rubin DA; Morrow JP; Avula UMR; Berman JP; Kushnir A; Abrams MP; Hennessey JA; Elias P; Poterucha TJ; Uriel N; Kubin CJ; LaSota E; Zucker J; Sobieszczyk ME; Schwartz A; Garan H; Waase MP; Wan EY
JAMA Netw Open; 2021 Apr; 4(4):e216842. PubMed ID: 33890991
[TBL] [Abstract][Full Text] [Related]
13. QTc evaluation in COVID-19 patients treated with chloroquine/hydroxychloroquine.
Monzani A; Genoni G; Scopinaro A; Pistis G; Kozel D; Secco GG
Eur J Clin Invest; 2020 Jun; 50(6):e13258. PubMed ID: 32356580
[No Abstract] [Full Text] [Related]
14. Incidence of arrhythmias and electrocardiographic abnormalities in symptomatic pediatric patients with PCR-positive SARS-CoV-2 infection, including drug-induced changes in the corrected QT interval.
Samuel S; Friedman RA; Sharma C; Ganigara M; Mitchell E; Schleien C; Blaufox AD
Heart Rhythm; 2020 Nov; 17(11):1960-1966. PubMed ID: 32621881
[TBL] [Abstract][Full Text] [Related]
15. Hydroxychloroquine in Covid-19: Does the end justify the means?
Yakoub-Agha I
Curr Res Transl Med; 2020 Aug; 68(3):81-82. PubMed ID: 32340837
[No Abstract] [Full Text] [Related]
16. COVID-19 and QT interval prolongation: more than just drug toxicity?
Merino JL; Martínez-Cossiani M; Iniesta A; Escobar C; Rey JR; Castrejón-Castrejón S
Europace; 2020 Oct; 22(10):1479. PubMed ID: 32441761
[No Abstract] [Full Text] [Related]
17. Saudi Heart Rhythm Society Task Force on Management of Potential Arrhythmogenicity Associated with Pharmacotherapy for COVID-19.
AlShoaibi NA; Maghrabi K; Alanazi H; Harbi MA; Alghamdi S
Ann Saudi Med; 2020; 40(5):365-372. PubMed ID: 32954790
[TBL] [Abstract][Full Text] [Related]
18. Ventricular repolarization indexes in patients treated with hydroxychloroquine - azithromycin combination for COVID-19.
Gunay S; Caliskan S; Sigirli D; Sahin E
Bratisl Lek Listy; 2020; 121(11):817-821. PubMed ID: 33164544
[TBL] [Abstract][Full Text] [Related]
19. QT interval evaluation associated with the use of hydroxychloroquine with combined use of azithromycin among hospitalised children positive for coronavirus disease 2019.
Tuncer T; Karaci M; Boga A; Durmaz H; Guven S
Cardiol Young; 2020 Oct; 30(10):1482-1485. PubMed ID: 32686633
[TBL] [Abstract][Full Text] [Related]
20. Chloroquine-induced torsades de pointes in a patient with coronavirus disease 2019.
Szekely Y; Lichter Y; Shrkihe BA; Bruck H; Oster HS; Viskin S
Heart Rhythm; 2020 Sep; 17(9):1452-1455. PubMed ID: 32380291
[No Abstract] [Full Text] [Related]
[Next] [New Search]
